Neovascularisation affecting the retina and optic disc is an unusual but a well recognised complication of posterior uveitis.'2 Such vessels may give rise to vitreous haemorrhage, which contributes significantly to the visual morbidity in this disease. The neovascularisation is associated in some cases with capillary closure on fluorescein angiography, and an angiogenic factor produced by ischaemic retina has been implicated in the pathogenesis.' However, new vessels may also appear in the eye unassociated with capillary clQsure,.and fluorescein angiography shows diffuse microvascular leakage. In these cases it has been postulated that the neovascularisation is a direct result of the inflammatory process, a causal relationship being inferred from the fact that the vessels tend to regress with adequate control of the inflammation.9 The natural history of this complication has not been adequately studied, and at present therapy is directed towards control of the inflammation with systemic immunosuppressants, with laser photocoagulation being reserved for direct treatment of neovascular fronds, or the ablation of ischaemic areas. We have examined the clinical course of neovascularisation in a retrospective study and the effects of medical and laser treatments.
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Patients and methods
The records of 200 patients with posterior uveitis of non-infectious aetiology who attended the Ophthalmology Department at St Thomas's Hospital over the last 12 years were examined. All patients with diabetes mellitus, systemic vascular disease, or haematological disorders were excluded from the study. Twenty-six patients were identified with retinal neovascularisation due to inflammatory eye disease rather than primary retinal ischaemia. Fifteen patients were male and eleven female. Eleven patients had a diagnosis of idiopathic retinal vasculitis, eight had histologically confirmed sarcoidosis, and seven had Behqet's disease. The age of the patients ranged from 6 to 45 years (mean 27 years). Patients had been followed up for a period of six months to 12 years (mean 4 years).
At each hospital visit a full ophthalmological assessment had been carried out, with particular note being made of inflammatory activity within the eye, the size and location of sites of neovascularisation and any associated retinal features-for example, periphlebitis, venous occlusion. Fluorescein angiography had been performed in all cases when new vessels were first noted, and follow-up angiograms were performed whenever clinically indicated. mg prednisolone daily, tapering as the ocular inflammation was controlled). In some cases other immunosuppressants (azathioprine, chlorambucil, colchicine, and cyclosporin A) had been added to this regimen, either to increase the anti-inflammatory effect or as steroid sparing agents. The indications for laser photocoagulation of peripheral retina in this series were recurrent vitreous haemorrhage, significant capillary closure on fluorescein angiography (at least one quadrant), or neovascularisation which was unaffected by full immunosuppressive treatment. The visual acuity was recorded at the end of followup and the reasons for a poor corrected visual acuity (worse than 6/9 Snellen) were documented. Some illustrative case histories are presented below.
Case reports CASE 1 A 16-year-old schoolgirl presented with a two-year history of intermittent poor vision in her right eye. Her general health was good and general examination was unremarkable. Visual acuity was 6/9 in the right eye and 6/5 in the left, and she had moderate posterior uveitis with ++ vitreous cells and some snowballs in both eyes. Two months later her right vision suddenly dropped to counting fingers due to a vitreous haemorrhage which, cleared to reveal new vessels on the right disc (Fig. 1A) . Fluorescein angiography showed peripheral microvascular leakage but no capillary closure (Fig. 1B) . She was treated with systemic steroids, and despite a further vitreous haemorrhage the new vessels disappeared three years after presentation (Fig. 1C) and her vision returned to 6/5 in each eye.
Comment. This case demonstrates that neovascularisation may regress with control of intraocular inflammation alone. A 34-year-old bricklayer had been diagnosed as a case of Eales' disease 11 years previously. On presentation to St Thomas's in 1976 the visual acuity was counting fingers in the right eye and 6/9 in the left. He had bilateral vitreous haemorrhages. The right fundus could not be seen, but the left showed extensive peripheral retinal new vessels, and capillary closure was demonstrated on fluorescein angiography. He was initially treated with laser photocoagulation to the left eye, but despite this he developed new vessels at the optic disc ( Fig. 2A) . He was treated with systemic steroids and a further course of laser treatment, and both the disc and peripheral new vessels regressed. However, his visual acuity remained poor at counting fingers in both eyes due to chronic macular oedema (Fig. 2B) .
Comment. This case illustrates that combined medical and laser treatment may be required to control neovascularisation but that cystoid macular oedema may develop despite such treatment. CASE 
3
A 28-year-old housewife had suffered from Behqet's disease for 10 years. On admission to St Thomas's Hospital the visual acuity was counting fingers in the right eye and 6/5 in the left. She had had recurrent vitreous haemorrhages in the right eye in which a traction retinal detachment involving the macula was present. An upper nasal branch vein occlusion was present in the left eye (Fig. 3A) . New vessels were present on both the optic discs (Fig. 3B, C) . She was treated with a reducing dose of systemic steroids, beginning with 60 mg daily, and the new vessels on the left optic disc resolved. However, she recently suffered a left inferotemporal branch vein occlusion involving the macula and has consequently developed more disc new vessels in the left eye (Fig. 3D) .
Comment. This case illustrates that new vessels may settle spontaneously on medical treatment despite the presence of capillary closure. CASE 4 A 34-year-old soldier with histologically confirmed sarcoidosis initially presented with blurred vision in the right eye due to posterior uveitis. The inflammation resolved following a course of systemic steroids, but six weeks later vision in the right eye was reduced owing to a vitreous haemorrhage. Fundus examination showed optic disc and peripheral neovascularisation associated with capillary closure (Fig. 4A ). Right panretinal photocoagulation was carried out, and the abnormal vessels regressed (Fig. 4B ). Six years later he presented with a further vitreous haemorrhage in the right eye, and more peripheral new vessels had developed. Further laser treatment was unsuccessful, and the right vision remained at hand movements due to persistent vitreous haemorrhage.
Comment. This case illustrates the initial beneficial effect of laser photocoagulation in the presence of capillary closure, though further treatment failed to produce regression of the new vessels. 
Results
(reduction of more than 3 lines on the Snellen chart). New vessels were found at the optic disc in 28 eyes In this study of 26 patients with retinal neovasculari-(72%) and elsewhere in the retina in 11 (28%). sation due to posterior uveitis, 39 eyes showed Active inflammation in the posterior segment (2+ evidence of new vessels. Vitreous haemorrhage was a cells or more), and a posterior vitreous detachment presenting feature in 22 eyes (56%), and in 12 of was present in all affected eyes. these (31%) it was a cause of significant visual loss
The fluorescein angiographic features are pre- The fate of the new vessels is shown in Table 5 . The new vessels resolved in 70% of cases (27 eyes) following treatment (medical and/or surgical), but in nine eyes the neovascular process was unaffected by treatment, and in three eyes assessment was not possible due to poor visibility.
Discussion
Neovascularisation is a fundamental element of the postinflammatory healing process in all parts of the body, and continues for as long as the appropriate angiogenic stimulus is present. In the eye such stimuli have been suggested to arise from hypoxic retina,> inflamed retina,"' or from inflammatory cells themselves." Previous series examining the natural history of new vessels in ocular inflammatory disease are few. The original paper by Eales'2 described young men with repeated intraocular haemorrhage, distended tortuous retinal veins, and retinal haemorr- reported on eight patients with sarcoidosis and retinal neovascularisation-six at the optic disc and two in the periphery associated with branch vein occlusion. Two of these are included in the present series and were treated by panretinal photocoagulation. The new vessels regressed in one, but the other developed macular oedema following treatment.
The present study has shown the clinical and angiographic features found in 39 eyes of 26 patients with neovascularisation due to posterior uveitis, and has attempted to assess their progress in response to medical and laser treatment. It is evident that such neovascularisation occurs in younger patients, and that the visual prognosis, even in the presence of significant vitreous haemorrhage, is good. In the majority of patients intraocular inflammation subsided on medical treatment, and in half of these This study indicates that retinal neovascularisation associated with ocular inflammation behaves in a different manner from retinal neovascularisation not associated with ocular inflammation. The visual prognosis is better in the presence of intraocular inflammation, and this is also true for vitreous haemorrhage. We would recommend that full and adequate medical treatment should be used to suppress the intraocular inflammation, with laser photocoagulation being reserved for further treatment once the eye is quiet and if recurrent vitreous haemorrhages occur.
